Dose-response relationship and within-subject variability of insulin detemir and NPH insulin in subjects with type 1 diabetes

被引：0
|
作者：
Wutte, A
Plank, J
Sinner, F
Druml, T
Sommer, R
Zdravkovic, M
Ronn, BB
Draeger, E
Pieber, TR
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A152 / A152
页数：1
相关论文
共 50 条
  • [41] Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands
    Valentine, W. J.
    Jendle, J.
    Saraheimo, M.
    Thorsteinsson, B.
    Pollock, R. F.
    Lammert, M.
    DIABETIC MEDICINE, 2012, 29 (03) : 303 - 312
  • [42] The Effects of Subcutaneous Insulin NPH and Detemir on Glucose Flux and Lipolysis Following a Period of Insulin Withdrawal in Patients With Type 1 Diabetes
    Herring, Roselle
    Shojaee-Moradie, Fariba
    Jackson, Nicola
    Jones, Richard
    Umpleby, Margot
    Russell-Jones, David L.
    DIABETES, 2013, 62 : A492 - A492
  • [43] Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes - A randomized clinical trial
    Home, P
    Bartley, P
    Russell-Jones, D
    Hanaire-Broutin, H
    Heeg, JE
    Abrams, P
    Landin-Olsson, M
    Hylleberg, B
    Lang, H
    Draeger, E
    DIABETES CARE, 2004, 27 (05) : 1081 - 1087
  • [44] Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes
    Miyazaki, Y
    Matsuda, M
    DeFronzo, RA
    DIABETES CARE, 2002, 25 (03) : 517 - 523
  • [45] Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH-IGF1-IGFBP axis in patients with type 1 diabetes
    Ma, Zhulin
    Christiansen, Jens Sandahl
    Laursen, Torben
    Lauritzen, Torsten
    Frystyk, Jan
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (04) : 471 - 479
  • [46] A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE-2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL
    Buysman, E.
    Conner, C.
    Liu, F.
    Aagren, M.
    Bouchard, J.
    VALUE IN HEALTH, 2011, 14 (03) : A98 - A98
  • [47] A Comparison of Insulin Adherence in Patients with Type 2 Diabetes Initiating Therapy with Insulin Detemir in a Pen Device or NPH Insulin in a Vial
    Buysman, Erin K.
    Conner, Christopher
    Liu, Fang
    Aagren, Mark
    Bouchard, Jonathan
    DIABETES, 2011, 60 : A628 - A628
  • [48] Amount and Type of Dietary Fat, Postprandial Glycemia, and Insulin Requirements in Type 1 Diabetes: A Randomized Within-Subject Trial
    Bell, Kirstine J.
    Fio, Chantelle Z.
    Twigg, Stephen
    Duke, Sally-Anne
    Fulcher, Gregory
    Alexander, Kylie
    McGill, Margaret
    Wong, Jencia
    Brand-Miller, Jennie
    Steil, Garry M.
    DIABETES CARE, 2020, 43 (01) : 59 - 66
  • [49] Insulin glargine versus NPH insulin in patients with type 1 diabetes
    Ratner, R
    DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
  • [50] Short-term Effects of NPH Insulin, Insulin Detemir, and Insulin Glargine on the IGF-IGFBP-GH Axis in Patients with Type 1 Diabetes
    Frystyk, Jan
    Ma, Zhulin
    Laursen, Torben
    Lauritzen, Torsten
    Christiansen, Jens S.
    DIABETES, 2014, 63 : A489 - A490
12345